31 gennaio 2022 – Due to the early regulatory revision of veterinary medicinal products legislation and the inclusion of the validity of GDP (Good Distribution Practice) for veterinary medicinal products and active substances in Annex 4 of the Medicinal Products Licensing Ordinance (ABMV; SR 812.212.1), the application forms for operating licences have been adapted. Activities requiring a licence can now be divided into veterinary medicinal products and human medicinal products, and active substances and intermediates can be selected for GDP activities.

For more information, see here.